— A drug wholesaler said Tuesday it’s investigating whether a lethal injection drug Arkansas bought and had planned to use in a now-halted execution came from a pharmacy that it supplies, a sale that the company says would have violated its contract with the pharmacy. The Pennsylvania-based company declined to name the pharmacy it believed may have sold the drug. Arkansas said it paid $250 in cash in August for enough of the drug to carry out two executions. The documents were released after the state Supreme Court ruled a 2015 law keeping the source of Arkansas’ execution drugs secret applied to sellers and suppliers of the drug, but not manufacturers. A case is pending before the state Supreme Court over a challenge from a medical supply company, which said it was misled by Arkansas prison officials who bought one of its execution drugs.

Source: National Post November 14, 2017 20:48 UTC